Keyphrases
Vanishing Bile Duct Syndrome
100%
Vaccination Strategy
100%
Drug-induced Liver Injury
100%
Human Papillomavirus Vaccine
100%
Gastrointestinal Cancer
100%
Primary Prevention
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Poor Outcome
100%
Cervical Cancer
66%
HBV-related Hepatocellular Carcinoma
66%
Hepatitis C Virus
66%
Hepatocellular Carcinoma
66%
Antibiotics
40%
Total Bilirubin
40%
Direct Bilirubin
40%
Taiwan
33%
Associated Morbidity
33%
Epidemiology
33%
Penile Cancer
33%
Immunization
33%
Hepatitis B Vaccine
33%
Vaccination Program
33%
Prophylactic Vaccination
33%
Vaccinated Population
33%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
33%
Anal Cancer
33%
Vulvar Cancer
33%
Vaccination Rate
33%
National Immunization Program
33%
Persistent Infection
33%
Hepatitis B Virus
33%
Vaginal Cancer
33%
Chronic Hepatitis C Virus Infection
33%
Countries Worldwide
33%
Sexually Transmitted Infections
33%
Cholestatic Liver Disease
20%
Risk Factors
20%
Clinical Treatment
20%
Offending
20%
Clinical Characteristics
20%
Treatment Information
20%
Clinical Laboratory Data
20%
Drug Class
20%
Demographic Data
20%
Lactams
20%
Offending Drugs
20%
Pediatric Case
20%
Long-term Complications
20%
Logistic Regression
20%
Synthetic Activity
20%
Medicine and Dentistry
Gastrointestinal Cancer
100%
Vanishing Bile Duct Syndrome
100%
Toxic Hepatitis
100%
Primary Prevention
100%
Wart Virus
100%
Hepatitis B Virus
80%
Hepatocellular Carcinoma
80%
Cervical Cancer
40%
Hepatitis C Virus
40%
Antibiotics
40%
Infection
40%
Bilirubin Glucuronide
40%
Chronic Hepatitis C
20%
Beta Lactam
20%
Cohort Effect
20%
Pediatrics
20%
Liver Disease
20%
Persistent Infection
20%
Disease
20%
Penile Cancer
20%
Vulvar Cancer
20%
Bilirubin
20%
Wart Virus Vaccine
20%
Anal Cancer
20%
Oropharyngeal Cancer
20%
Vagina Cancer
20%
Logistic Regression Analysis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Vaccination Policy
100%
Syndrome
100%
Toxic Hepatitis
100%
Digestive System Cancer
100%
Human Papillomavirus
83%
Hepatitis B Virus
66%
Liver Cell Carcinoma
66%
Bilirubin Glucuronide
40%
Hepatitis C Virus
33%
Infection
33%
Uterine Cervix Cancer
33%
Beta Lactam
20%
Antibiotics
20%
Disease
20%
Bilirubin
20%
Antibiotic Agent
20%
Liver Disease
20%
Chronic Hepatitis C
16%
Penis Cancer
16%
Vagina Cancer
16%
Anus Cancer
16%
Persistent Infection
16%
Wart Virus Vaccine
16%
Oropharynx Cancer
16%
